Interview with Glib Zagoriy, CEO, Darnitsa
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Address: ZAO Darnitsa Pharmaceutical Firm, 13 Ulitsa Borispolskaya, Kiev, 02093,Ukraine
Tel: (+38 044) 207-73-18
Web: http://darnitsa.ua/
In October 1930 the Ukrainian Institute of Experimental Endocrinology was founded in the Ukrainian capital Kiev. Few people then knew that the new buildings of the institute, built in 1938 in the Darnytskyi district of the capital, would be the basis of the largest chemical and pharmaceutical association in Ukraine. Darnitsa gave a powerful impetus to the development of modern pharmaceutical industry in Ukraine. The modern history of the company began in 1994, when the company was significantly reorganized.
Darnitsa’s use of innovative technologies and equipment along with compliance with the GMP and the introduction of quality management guarantees the production of a wide range of products under controlled conditions and ensures flexibility and mobility of production, optimal pricing and high quality and efficiency.
Darnitsa invest a significantly, not only in research and technology development, but also in the development of human resources. Effective use of the intellectual capacity of the staff – that the success of their business.
Antibiotics
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Dr. Natalya Gudz, head of the State Service of Ukraine on Medicines and Drugs Control (SMDC), provides her vision for the development of Ukraine’s key regulatory authority and the win-win…
Denis Shevchenko, founder of the NGO and charitable foundation PharmVarta, provides insights into the main initiatives of this independent, non-profit organization that has freely supplied Ukrainian patients with more than…
Alexander Markus, chairman of the board of the recently set up German-Ukrainian Chamber of Industry and Commerce, provides insights into the new dynamics driving the growth of Ukraine’s foreign trade…
Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis…
As the first Ukrainian pharmaceutical company backed by foreign capital, explain to us how the idea of creating “Sperco Ukraine” as a joint-venture with UCRAFARMA emerged? The idea to create…
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
Nobel Pharma has quite a history in the CIS region as this region is becoming increasingly important for the company. What is the company’s story in Ukraine? Nobel Pharma Ukraine…
Let us start with the history of InterChem which is quite unique and started as a chemical company with a very small group from the National Academy of Sciences. Please…
It has been almost a decade since Mili Healthcare began its operations in Ukraine today becoming one of the top 20 leading foreign companies in the local industry. What were…
What was the vision behind the creation of APRaD back in 2007 and what was lacking in the market at that time that called for such an association? APRaD originated…
You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing…
Since 2006 Teva has been on a solid phase of growth and consolidation, mainly through the acquisitions of IVAX in 2006, Pliva (Barr) in 2008 and ratiopharm in 2010, which…
See our Cookie Privacy Policy Here